Quidel Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Quidel Corp (QDEL) Tops Q3 EPS by 10c, Revenues Miss
November 6, 2018 4:26 PM ESTQuidel Corp (NASDAQ: QDEL) reported Q3 EPS of $0.59, $0.10 better than the analyst estimate of $0.49. Revenue for the quarter came in at $117.4 million versus the consensus estimate of $120.1 million.
Total revenue was $117.4 million as compared to $50.9 million in the third quarter of 2017.Cardiac Immunoassay revenue was $65.3 million.Influenza revenue was $21.6 million as compared to $23.1 million in the third quarter of 2017.Reported GAAP EPS of $0.27 per... More